Comparative analysis of clinical features of lower respiratory tract infection with respiratory syncytial virus and influenza virus in adults: a retrospective study.
Clinical characteristic
Comparison and analysis
Influenza virus
Lower respiratory tract infection
Respiratory syncytial virus
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
27
04
2023
accepted:
10
09
2023
medline:
18
9
2023
pubmed:
16
9
2023
entrez:
15
9
2023
Statut:
epublish
Résumé
Respiratory syncytial virus (RSV) infection in adults remains less recognized and understood, both socially and clinically, compared to influenza virus infection. This retrospective study aims to delineate and compare the clinical manifestations of adult RSV and influenza virus infections in the lower respiratory tract, thereby enhancing awareness of RSV lower respiratory tract infection and providing strategic insights for its prevention and treatment. Clinical data from January 2019 to December 2020 were analyzed for 74 patients with RSV and 129 patients with influenza A/B virus lower respiratory tract infections who were admitted to respiratory or intensive care units. All patients had complete clinical data with positive IgM and negative IgG viral antibodies. Comparison parameters included onset timing, baseline data, clinical manifestations, supplementary examination results, treatment methods, and prognosis, while logistic regression was employed to ascertain the correlation of clinical features between the two patient groups. In comparison to the influenza group, the RSV group presented less frequently with fever at admission but exhibited a higher incidence of dyspnea and wheezing on pulmonary auscultation (P < 0.01). RSV infection was more prevalent among patients with underlying diseases, particularly chronic obstructive pulmonary disease (COPD) and demonstrated a higher probability of co-infections, most notably with Mycoplasma (P < 0.01). The RSV group had significantly higher lymphocyte counts (P < 0.01) and exhibited more incidences of pleural thickening, pulmonary fibrosis, and emphysema (P < 0.05). The use of non-invasive mechanical ventilation was more common, and hospital stays were longer in the RSV group compared to the influenza group (P < 0.05). Logistic multivariate regression analysis further revealed that age and tachypnea incidence were significantly higher in the RSV group (P < 0.05). Compared to influenza virus infection, adults with COPD are more susceptible to RSV infection. Moreover, RSV infection elevates the risk of co-infection with Mycoplasma and may lead to conditions such as pleural thickening, pulmonary fibrosis, and emphysema. The requirement for non-invasive mechanical ventilation is higher in RSV-infected patients, who also tend to have longer hospital stays. Therefore, greater awareness and preventive strategies against RSV infection are imperative.
Sections du résumé
BACKGROUND
BACKGROUND
Respiratory syncytial virus (RSV) infection in adults remains less recognized and understood, both socially and clinically, compared to influenza virus infection. This retrospective study aims to delineate and compare the clinical manifestations of adult RSV and influenza virus infections in the lower respiratory tract, thereby enhancing awareness of RSV lower respiratory tract infection and providing strategic insights for its prevention and treatment.
METHODS
METHODS
Clinical data from January 2019 to December 2020 were analyzed for 74 patients with RSV and 129 patients with influenza A/B virus lower respiratory tract infections who were admitted to respiratory or intensive care units. All patients had complete clinical data with positive IgM and negative IgG viral antibodies. Comparison parameters included onset timing, baseline data, clinical manifestations, supplementary examination results, treatment methods, and prognosis, while logistic regression was employed to ascertain the correlation of clinical features between the two patient groups.
RESULTS
RESULTS
In comparison to the influenza group, the RSV group presented less frequently with fever at admission but exhibited a higher incidence of dyspnea and wheezing on pulmonary auscultation (P < 0.01). RSV infection was more prevalent among patients with underlying diseases, particularly chronic obstructive pulmonary disease (COPD) and demonstrated a higher probability of co-infections, most notably with Mycoplasma (P < 0.01). The RSV group had significantly higher lymphocyte counts (P < 0.01) and exhibited more incidences of pleural thickening, pulmonary fibrosis, and emphysema (P < 0.05). The use of non-invasive mechanical ventilation was more common, and hospital stays were longer in the RSV group compared to the influenza group (P < 0.05). Logistic multivariate regression analysis further revealed that age and tachypnea incidence were significantly higher in the RSV group (P < 0.05).
CONCLUSION
CONCLUSIONS
Compared to influenza virus infection, adults with COPD are more susceptible to RSV infection. Moreover, RSV infection elevates the risk of co-infection with Mycoplasma and may lead to conditions such as pleural thickening, pulmonary fibrosis, and emphysema. The requirement for non-invasive mechanical ventilation is higher in RSV-infected patients, who also tend to have longer hospital stays. Therefore, greater awareness and preventive strategies against RSV infection are imperative.
Identifiants
pubmed: 37715219
doi: 10.1186/s12890-023-02648-5
pii: 10.1186/s12890-023-02648-5
pmc: PMC10504734
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
350Subventions
Organisme : Science and Technology Fund of Guizhou Provincial Health Commission
ID : ([gzwkj2023-017])
Organisme : Science and Technology Bureau Project of Zunyi City
ID : (Zunshi Kehe HZ [2020]292)
Organisme : Guizhou Provincial Respiratory Critical Disease Clinical Research and Prevention and Treatment Talent Base Project
ID : [2020]8
Organisme : Zunyi Respiratory Medicine Talent Base Project
ID : ([2019]69)
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
BMJ Open. 2022 Dec 19;12(12):e060805
pubmed: 36535718
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
Exp Lung Res. 2005 Sep;31 Suppl 1:77
pubmed: 16395866
Influenza Other Respir Viruses. 2020 Sep;14(5):483-490
pubmed: 32449300
Influenza Other Respir Viruses. 2022 Sep;16(5):906-915
pubmed: 35474419
J Clin Virol. 2020 Dec;133:104685
pubmed: 33220548
Chest. 2022 Jun;161(6):1434-1435
pubmed: 35680305
Chest. 2022 Jun;161(6):1475-1484
pubmed: 35063450
Inflammation. 2018 Mar;41(2):654-666
pubmed: 29264743
Risk Manag Healthc Policy. 2021 Apr 14;14:1525-1531
pubmed: 33889036
Influenza Other Respir Viruses. 2020 Nov;14(6):658-670
pubmed: 32064773
J Infect Dis. 2020 Oct 7;222(Suppl 7):S577-S583
pubmed: 30880339
Front Cell Infect Microbiol. 2017 Aug 03;7:338
pubmed: 28824877
Curr Infect Dis Rep. 2020 Jan 24;22(1):3
pubmed: 31980966
J Med Virol. 2020 Apr;92(4):408-417
pubmed: 31944312
J Infect Dis. 2022 Aug 12;226(Suppl 1):S87-S94
pubmed: 35961055
Adv Ther. 2020 Mar;37(3):1203-1217
pubmed: 32026380
Clin Infect Dis. 2021 Jul 1;73(1):e158-e163
pubmed: 32531019
Clin Infect Dis. 2019 Jul 2;69(2):197-203
pubmed: 30452608
J Med Virol. 2021 Aug;93(8):4638-4646
pubmed: 33792930
Viruses. 2021 Aug 30;13(9):
pubmed: 34578306
BMJ. 2019 Sep 10;366:l5021
pubmed: 31506273
J Clin Microbiol. 2016 Dec 28;55(1):79-89
pubmed: 27795341
BMC Public Health. 2017 Mar 21;17(1):271
pubmed: 28320361
Front Microbiol. 2022 Mar 31;13:819931
pubmed: 35432263
Eur Respir Rev. 2022 Nov 15;31(166):
pubmed: 36384703
Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59
pubmed: 21951385